B+
Bull case
0%
Probability
Target price
$57.00
-5.0% vs current
CNC
CenteneANYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
0%
Probability
Target price
$48.00
-20.0% vs current
B-
Bear case
0%
Probability
Target price
$39.00
-35.0% vs current
AI sentiment snapshot
Latest data as of 2026-04-29
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+27.7
Score
AI commentary
News tone turned clearly better on April 28-29, 2026 after the earnings beat, guidance increase, and margin-recovery commentary. Immediate market reaction was positive, with outside coverage describing a sharp post-print rise and premarket strength, and follow-up analyst notes turned more constructive. Peer context is now anchored to managed-care competitors rather than the packet's generic health-care equipment candidates, but fully refreshed consensus and broad peer revision data are still limited, so sentiment has improved faster than conviction.
RankAlpha Sentiment Codex - 2026-04-29
Open full AI memoEvidence flagged
peer set is too generic or lacks enough direct operating comparators
Impact
tentative
Confidence
-
AI events
2026-04-28eventQ1 beat and higher 2026 guide reset the near-term narrativeHigh impact
Centene's April 28 earnings release reported adjusted diluted EPS of $3.37, about $0.50 above management's expectations, and raised 2026 premium and service revenue guidance by $1.0 billion to $171.0-$175.0 billion while lifting adjusted EPS guidance to greater than $3.40, reinforcing the margin-recovery thesis.[#8-K-2026-04-28]
2026-04-29catalystPost-earnings analyst revisions are turning more constructiveMedium impact
Follow-through coverage on April 29 pointed to improving confidence in Medicaid margin recovery, including Bank of America and Cantor Fitzgerald upgrades cited by Investing.com, with Cantor raising its target to $60 from $41; this helps validate the beat-and-raise but also suggests the next leg higher depends on broader estimate revisions rather than the print alone.
2026-12-31catalystMargin recovery has become more visible but still needs durability proofHigh impact
Primary-source operating drivers were better Medicaid medical cost management, moderate flu, Medicare outperformance, disciplined SG&A, and $1.0 billion of debt reduction, but the recovery still must offset lower Marketplace and Medicaid membership and prove durable through the rest of 2026.[#8-K-2026-04-28]
Recommendation
N/A
No formal recommendation provided.
As of 2026-04-29 • Updated nightlySource: Internal modelMethodology